fiberoptic bronchoscopy
Conditions
Interventions
Experimental group:Intravenous remazolam 0.2mg/kg and fentanyl 0.5 g/kg were administered for sedation
Control group:Intravenous midazolam 0.075mg/kg and fentanyl 0.5 g/kg were administered for sedation
Sponsors
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Select elderly patients who will undergo fiber bronchoscopy in our hospital from July 2021 to June 2022; 2. No gender limit; 3. Aged 60 to 80 years; 4. Body mass index < 30kg/m^2; 5. ASA classification I~II; 6. Elderly patients without hypertension, heart disease, or severe carbon dioxide accumulation before surgery.
Exclusion criteria
Exclusion criteria: 1. Exclude the operation time >30minzhe, exclude those suffering from neuropsychiatric diseases and taking related drugs; 2. Having damage to target organs such as liver, kidney, heart and brain; 3. Allergic to narcotic drugs; 4. Unable to communicate with a doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time the drug takes effect;Opioid use dose;Intraoperative vital signs;Intraoperative adverse events;awake time; | — |
Secondary
| Measure | Time frame |
|---|---|
| operation time; | — |
Countries
China
Contacts
Public ContactSun Jianliang
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Outcome results
None listed